IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a ...

IRBM, an integrated Contract Research Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform to support genetic target ...

Researchers designed a CRISPR-based test that rapidly detects low levels ... It also detected multi-drug-resistant Staphylococcus aureus DNA without prior amplification at concentrations that ...

highly sensitive detection of multi-drug-resistant bacteria and other pathogens at low concentrations. Researchers designed a CRISPR-based test that rapidly detects low levels of pathogen genetic ...

that it says build the case for the drug as a phase 3 trial gets underway – but its shares fell sharply as investors reacted to the news. The CRISPR specialist said that a single 50mg infusion ...

CRISPR gene editing technology has been heralded as a revolutionary breakthrough in drug development, enabling scientists to potentially cure genetic diseases by modifying the genes that cause them.

Professor Rashid Bashir and a research team at the Grainger College of Engineering, Urbana, Illinois have developed a novel ...

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a ...

“Using our nano-lipid delivery system, we injected the drug directly into the tumor in a tumor model and successfully took out the gene – literally cutting it out from the cancer cell’s DNA with the ...

Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) - a life-threatening fungal infection primarily affecting children and ...

Now, a new CRISPR-based test has been developed to diagnose PJP more quickly and less invasively. Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis ...